Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease

Ilya Danelich(AstraZeneca (South Korea)), Brent N. Reed(University of Maryland, Baltimore), Sampaguita S. Wright(Mayo Clinic in Arizona), Jennifer M. Lose(Mayo Clinic in Arizona), Brittany J. Tefft(Mayo Clinic), Jonathan D. Cicci(University of North Carolina Hospitals)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
May 1, 2015
10.1002/phar.1584
Cited by 55

Related Papers

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
|JAMA Neurology|2024|88
Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
|Journal of the American College of Surgeons|2014|73
Role of clinical pharmacists and pharmacy support personnel in transitions of care
|JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY|2020|40
Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2016|29
Clinical <scp>U</scp> pdate on the <scp>M</scp> anagement of <scp>A</scp> trial <scp>F</scp> ibrillation
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2013|20